Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2024, Vol 13, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
News and Views
1. Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
Mohammad Reza Ardalan*
J Renal Inj Prev
. 2013;2(2): 71-72.
doi:
10.12861/jrip.2013.23
PMCID:
PMC4206017
PMID:
25340132
Article
PDF
XML
Cited By:
0
×
Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
Case Report
2. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
Wisit Cheungpasitporn, Stephen L. Kopecky, Ulrich Specks, Kharmen Bharucha, Fernando C. Fervenza
J Renal Inj Prev
. 2017;6(1): 18-25.
doi:
10.15171/jrip.2017.04
PMCID:
PMC5414514
PMID:
28487867
Scopus ID:
85040672073
Article
PDF
XML
Cited By:
36
12
32
×
Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
Original
3. Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience
Monika Yachha, Raj Kumar Sharma*, Sonia Mehrotra, Narayan Prasad, Amit Gupta, Anupma Kaul, Dharmendra Singh Bhadauria
J Renal Inj Prev
. 2018;7(1): 16-21.
doi:
10.15171/jrip.2018.04
Scopus ID:
85042628444
Article
PDF
XML
Cited By:
2
2
×
Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience